This conference will discuss cancer care, prevention and research in England.
It is bringing together key stakeholders to assess progress on meeting the national targets set for cancer in the NHS Long Term Plan.
We also expect discussion to focus on the impact of the COVID-19 pandemic on those affected by cancer, their diagnosis and treatment and what can be learned for the future from steps that the NHS is taking to enable patients to continue treatment and have check-ups, including the establishment of COVID-free cancer hubs.
It comes with NHS England warning people still to come forward if they have any concerns around cancer symptoms during the COVID-19 pandemic amid reports of a significant proportion of service users having worries around getting help.
- Meeting national ambitions for cancer care, the impact of COVID-19 and priorities going forward;
- Developing Cancer Alliances - progress, integrated care and implementing 5 Year Plans;
- Priorities for cancer screening and prevention - accountability, accessibility and reducing inequalities;
- Cancer diagnosis and care in England - progress of Rapid Diagnostic Centres, workforce priorities, meeting diagnostic capacity and delivering personalised care;
- Assessing the next steps for less survivable cancer outcomes;
- Increasing access to innovative cancer research and technologies - the use of genomics and AI, building trust, developing adoption and the role of regulation;
- Progress of the Cancer Drugs Fund and next steps for improving access to cancer drugs.